Healthcare & Life Sciences
Palladio Biosciences
United Statespalladiobio.com
Palladio Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Palladio Biosciences
Based in the United States, Palladio Biosciences is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Palladio Biosciences is developing lixivaptan, a drug candidate in Phase 3 clinical trials for the treatment of autosomal dominant polycystic kidney disease (ADPKD), a chronic genetic kidney disorder characterized by fluid-filled cysts.
Explore Palladio Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.